SENORES PHARMA : USFDA INSPECTION COMPLETED AT SUBSIDIARY FACILITY

• Apnar Pharma Private Limited's Vadodara manufacturing facility passed its USFDA inspection. • The inspection, conducted from September 07, 2026, to September 11, 2026, yielded one minor procedural observation and no GMP-related issues. • The subsidiary will submit its response to the observation within the stipulated timeframe.

Senores Pharmaceuticals Ltd

Open attachment

← Back to feed